WallStSmart

ICL Israel Chemicals Ltd (ICL)vsNexentis Technologies Inc. (NXTS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ICL Israel Chemicals Ltd generates 3689852% more annual revenue ($7.71B vs $209,000). ICL leads profitability with a 4.0% profit margin vs 0.0%. NXTS trades at a lower P/E of 0.2x. ICL earns a higher WallStSmart Score of 59/100 (C).

ICL

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 5.0Value: 4.7Quality: 6.0
Piotroski: 2/9Altman Z: 2.13

NXTS

Avoid

24

out of 100

Grade: F

Growth: 3.7Profit: 3.0Value: 6.7Quality: 6.5
Piotroski: 3/9Altman Z: -0.92
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ICLUndervalued (+0.5%)

Margin of Safety

+0.5%

Fair Value

$5.78

Current Price

$5.36

$0.42 discount

UndervaluedFair: $5.78Overvalued

Intrinsic value data unavailable for NXTS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ICL3 strengths · Avg: 9.3/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
51.6%10/10

Earnings expanding 51.6% YoY

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

NXTS3 strengths · Avg: 9.7/10
P/E RatioValuation
0.2x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

Areas to Watch

ICL4 concerns · Avg: 2.8/10
Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
9.442/10

Expensive relative to growth rate

NXTS4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$2.08M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 16.5% demonstrates continued momentum.

Bull Case : NXTS

The strongest argument for NXTS centers on P/E Ratio, Price/Book, Debt/Equity.

Bear Case : ICL

The primary concerns for ICL are Return on Equity, Profit Margin, Piotroski F-Score. Thin 4.0% margins leave little buffer for downturns.

Bear Case : NXTS

The primary concerns for NXTS are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

ICL profiles as a growth stock while NXTS is a value play — different risk/reward profiles.

NXTS carries more volatility with a beta of 1.87 — expect wider price swings.

ICL is growing revenue faster at 16.5% — sustainability is the question.

ICL generates stronger free cash flow (93M), providing more financial flexibility.

Bottom Line

ICL scores higher overall (59/100 vs 24/100) and 16.5% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Nexentis Technologies Inc.

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nexentis Technologies Inc. develops and operates an AI and data-driven computational biotech platform. The company is headquartered in Hod HaSharon, Israel.

Want to dig deeper into these stocks?